Ultragenyx Pharmaceutical Inc(RARE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RARE Ultragenyx Pharmaceutical Inc

休市中 05-17 16:00:00 EDT

41.87

-0.74

-1.74%

盘后41.87

+0.000.00%

16:05 EDT

最高43.08	最低41.76	成交量80.30万
今开42.70	昨收42.61	日振幅3.10%
总市值34.78亿	流通市值30.74亿	总股本8,307万
成交额3,385万	换手率1.09%	流通股本7,341万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical Inc","latestPrice":41.87,"timestamp":1715976000000,"preClose":42.61,"halted":0,"volume":802954,"hourTrading":{"tag":"盘后","latestPrice":41.87,"preClose":41.87,"latestTime":"16:05 EDT","volume":20380,"amount":853309.34,"timestamp":1715976331702},"delay":0,"floatShares":73413736,"shares":83069766,"eps":-7.968776,"marketStatus":"休市中","marketStatusCode":7,"change":-0.74,"latestTime":"05-17 16:00:00 EDT","open":42.7,"high":43.08,"low":41.76,"amount":33851290.440622,"amplitude":0.030979,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.968776,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1391144400000,"adjPreClose":42.61,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":42.78,"preClose":42.61,"latestTime":"09:28 EDT","volume":407,"amount":17421.50883,"timestamp":1715952480056},"postHourTrading":{"tag":"盘后","latestPrice":41.87,"preClose":41.87,"latestTime":"16:05 EDT","volume":20380,"amount":853309.34,"timestamp":1715976331702},"volumeRatio":1.1724369541417303},"requestUrl":"/m/hq/s/RARE/tweets","defaultTab":"tweets","newsList":[{"id":"2434879310","title":"Ultragenyx Pharmaceutical Inc.2024财年第一财季实现净利润-1.71亿美元，同比减少4.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434879310","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434879310?lang=zh_cn&edition=full","pubTime":"2024-05-12 00:18","pubTimestamp":1715444307,"startTime":"0","endTime":"0","summary":"3月31日，Ultragenyx Pharmaceutical Inc.公布财报，公告显示公司2024财年第一财季净利润为-1.71亿美元，同比减少4.27%；其中营业收入为1.09亿美元，同比增加9.00%，每股基本收益为-2.03美元。机构评级：截至2024年3月31日，当前有21家机构对Ultragenyx Pharmaceutical Inc.目标价做出预测，其中目标均价为89.00美元，其中最低目标价为47.00美元，最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120018298af92759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120018298af92759&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429945013","title":"Ultragenyx Pharmaceutical(RARE.US)获加拿大皇家银行首次覆盖，给予优于大市评级, 目标价77.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429945013","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429945013?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:55","pubTimestamp":1713779754,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical(RARE.US)获加拿大皇家银行首次覆盖，给予优于大市评级, 目标价77.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221755578b45aad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221755578b45aad9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427000685","title":"Ultragenyx Pharmaceutical Inc.盘中异动 早盘大幅下跌7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427000685","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427000685?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:31","pubTimestamp":1713187910,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时31分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价快速下挫7.66%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为591.11%、347.01%、254.45%，振幅较大的相关个股有Organovo Holdings, Inc.、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为28.71%、24.09%、19.37%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojolvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131508b263f79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131508b263f79&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417486874","title":"Ultragenyx Pharmaceutical Inc.盘中异动 早盘快速下跌5.08%报50.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417486874","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417486874?lang=zh_cn&edition=full","pubTime":"2024-03-05 23:08","pubTimestamp":1709651285,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日23时08分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价快速下挫5.08%。截至发稿，该股报50.60美元/股，成交量9.002万股，换手率0.11%，振幅4.87%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为1.38%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojolvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305230806861db6f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305230806861db6f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414849832","title":"美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2414849832","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414849832?lang=zh_cn&edition=full","pubTime":"2024-02-27 15:31","pubTimestamp":1709019083,"startTime":"0","endTime":"0","summary":"    路透社2月27日 - 华尔街证券分析师周二调整了对 Agiliti、多米诺比萨和 Krystal Biotech 等几家美国上市公司的评级和目标价。公司要闻             * Agiliti公司  ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * 多米诺比萨  ：杰富瑞将目标价从400美元上调至455美元              * Krystal Biotech Inc   ：Evercore ISI将其股票从战术跑赢大盘名单中除名  以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413279854","title":"Ultragenyx Pharmaceutical Inc2023财年实现净利润-6.07亿美元，同比增加14.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413279854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413279854?lang=zh_cn&edition=full","pubTime":"2024-02-23 07:18","pubTimestamp":1708643938,"startTime":"0","endTime":"0","summary":"12月31日，Ultragenyx Pharmaceutical Inc公布财报，公告显示公司2023财年净利润为-6.07亿美元，同比增加14.14%；其中营业收入为4.34亿美元，同比增加19.56%，每股基本收益为-8.25美元。机构评级：截至2023年12月31日，当前有20家机构对Ultragenyx Pharmaceutical Inc目标价做出预测，其中目标均价为89.65美元，其中最低目标价为48.00美元，最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022307190881aa54cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022307190881aa54cd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411390896","title":"Ultragenyx Pharmaceutical Inc   预计每股亏损1.62美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2411390896","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411390896?lang=zh_cn&edition=full","pubTime":"2024-02-14 05:39","pubTimestamp":1707860379,"startTime":"0","endTime":"0","summary":"   * Ultragenyx Pharmaceutical Inc    将于2月15日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，14位分析师的平均预期显示，这家总部位于加利福尼亚州诺瓦托的公司的营收将从去年同期的1.0335亿美元增至1.1938亿美元，增幅为15.5%。* LSEG 分析师对 Ultragenyx Pharmaceutical Inc 的平均预期是每股亏损 1.62 美元。* 华尔街对 Ultragenyx Pharmaceutical Inc 的 12 个月目标价中位数为 82.00 美元，高于其上次收盘价 46.74 美元。2月13日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2404048328","title":"美国研究综述-Burlington Stores、Carrols Restaurant Group、Mastec","url":"https://stock-news.laohu8.com/highlight/detail?id=2404048328","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2404048328?lang=zh_cn&edition=full","pubTime":"2024-01-17 15:02","pubTimestamp":1705474948,"startTime":"0","endTime":"0","summary":"    路透1月17日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括伯灵顿百货公司、Carrols Restaurant Group 和 Mastec。要点             * Ambrx Biopharma Cayman Inc   ：贝雅将其评级下调至中性             * Burlington Stores Inc   ：Piper Sandler将其评级从中性上调至增持              * Carrols Restaurant Group Inc   ：Stephens将其评级从 \"增持 \"下调至 \"等权重\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ultragenyx.com","stockEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":-0.0508},{"period":"3month","weight":-0.1441},{"period":"6month","weight":0.0475},{"period":"1year","weight":-0.1777},{"period":"ytd","weight":-0.1244}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ultragenyx Pharmaceutical Inc.于2010年4月22日成立，是一家处于发展阶段的生物科技企业，公司随后于2011年6月在特拉华州重新注册成立。公司专注于新型产品的鉴定、收购、开发与商业化，该产品主要用于治疗罕见和极罕见的疾病，产品最初目标是用于治疗严重的，令人衰弱的代谢基因类疾病。公司目前用于治疗遗传性包涵体肌病患者的缓释唾液酸正处于临床试验第二阶段，该疾病是一种渐进式的肌肉萎缩疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.014003},{"month":2,"riseRate":0.636364,"avgChangeRate":0.079614},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.047001},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.001553},{"month":5,"riseRate":0.454545,"avgChangeRate":0.047423},{"month":6,"riseRate":0.7,"avgChangeRate":0.068734},{"month":7,"riseRate":0.4,"avgChangeRate":0.015854},{"month":8,"riseRate":0.5,"avgChangeRate":0.006387},{"month":9,"riseRate":0.2,"avgChangeRate":-0.064028},{"month":10,"riseRate":0.2,"avgChangeRate":-0.074469},{"month":11,"riseRate":0.5,"avgChangeRate":0.050565},{"month":12,"riseRate":0.7,"avgChangeRate":0.064436}],"exchange":"NASDAQ","name":"Ultragenyx Pharmaceutical Inc","nameEN":"Ultragenyx Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ultragenyx Pharmaceutical Inc(RARE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ultragenyx Pharmaceutical Inc(RARE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ultragenyx Pharmaceutical Inc,RARE,Ultragenyx Pharmaceutical Inc股票,Ultragenyx Pharmaceutical Inc股票老虎,Ultragenyx Pharmaceutical Inc股票老虎国际,Ultragenyx Pharmaceutical Inc行情,Ultragenyx Pharmaceutical Inc股票行情,Ultragenyx Pharmaceutical Inc股价,Ultragenyx Pharmaceutical Inc股市,Ultragenyx Pharmaceutical Inc股票价格,Ultragenyx Pharmaceutical Inc股票交易,Ultragenyx Pharmaceutical Inc股票购买,Ultragenyx Pharmaceutical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ultragenyx Pharmaceutical Inc(RARE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ultragenyx Pharmaceutical Inc(RARE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}